Kevin S.  Wilson net worth and biography

Kevin Wilson Biography and Net Worth

CEO of Heska
Kevin S. Wilson was appointed President and Chief Executive Officer effective March 31, 2014. He previously served as our President and Chief Operating Officer from February 2013. Mr. Wilson became a member of our Board of Directors in May 2014. Mr. Wilson is a founder, member and officer of Cuattro, LLC, an imaging diagnostic company. Since 2008, he has been involved in developing technologies for radiographic imaging with Cuattro, LLC and as a founder of Cuattro Software, LLC, Cuattro Medical, LLC and Cuattro Veterinary, LLC. Mr. Wilson served on the board of various private, non-profit and educational organizations from 2005 to 2011. He was a founder of Sound Technologies, Inc., a diagnostic imaging company, in 1996. After Sound Technologies, Inc. was sold to VCA Antech, Inc. in 2004, Mr. Wilson served as Chief Strategy Officer for VCA Antech, Inc. until 2006. Mr. Wilson attended Saddleback College.

What is Kevin S. Wilson's net worth?

The estimated net worth of Kevin S. Wilson is at least $20.05 million as of January 6th, 2023. Mr. Wilson owns 167,072 shares of Heska stock worth more than $20,046,969 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Wilson may own. Additionally, Mr. Wilson receives a salary of $988,170.00 as CEO at Heska. Learn More about Kevin S. Wilson's net worth.

How old is Kevin S. Wilson?

Mr. Wilson is currently 51 years old. There are 6 older executives and no younger executives at Heska. Learn More on Kevin S. Wilson's age.

What is Kevin S. Wilson's salary?

As the CEO of Heska Co., Mr. Wilson earns $988,170.00 per year. Learn More on Kevin S. Wilson's salary.

How do I contact Kevin S. Wilson?

The corporate mailing address for Mr. Wilson and other Heska executives is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. Heska can also be reached via phone at (970) 493-7272 and via email at [email protected]. Learn More on Kevin S. Wilson's contact information.

Has Kevin S. Wilson been buying or selling shares of Heska?

Kevin S. Wilson has not been actively trading shares of Heska in the last ninety days. Most recently, on Friday, January 6th, Kevin S. Wilson bought 11,018 shares of Heska stock. The stock was acquired at an average cost of $58.62 per share, with a total value of $645,875.16. Following the completion of the transaction, the chief executive officer now directly owns 167,072 shares of the company's stock, valued at $9,793,760.64. Learn More on Kevin S. Wilson's trading history.

Who are Heska's active insiders?

Heska's insider roster includes Catherine Grassman (CFO), Sharon Larson (Director), Kevin Wilson (CEO), and Nancy Wisnewski (COO). Learn More on Heska's active insiders.

Kevin S. Wilson Insider Trading History at Heska

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/6/2023Buy11,018$58.62$645,875.16167,072View SEC Filing Icon  
12/22/2022Buy3,440$59.64$205,161.60156,054View SEC Filing Icon  
11/23/2021Buy1,000$173.00$173,000.00View SEC Filing Icon  
11/15/2021Buy1,000$179.00$179,000.00View SEC Filing Icon  
10/21/2020Sell13,421$110.28$1,480,067.8872,955View SEC Filing Icon  
10/8/2020Sell3,129$109.00$341,061.00
8/5/2020Sell9,176$107.13$983,024.8872,955View SEC Filing Icon  
6/5/2020Sell10,000$91.00$910,000.0082,955View SEC Filing Icon  
6/3/2020Sell9,707$89.00$863,923.0082,955View SEC Filing Icon  
5/28/2020Sell6,234$87.09$542,919.06104,955View SEC Filing Icon  
5/26/2020Sell3,266$85.00$277,610.00104,955View SEC Filing Icon  
5/19/2020Sell1,734$85.00$147,390.00108,221View SEC Filing Icon  
11/30/2018Sell1,631$104.00$169,624.00View SEC Filing Icon  
11/28/2018Sell181$104.00$18,824.00106,629View SEC Filing Icon  
11/9/2018Sell3,190$104.07$331,983.30106,810View SEC Filing Icon  
3/6/2017Sell8,000$90.00$720,000.00110,000View SEC Filing Icon  
8/29/2016Sell20,000$51.80$1,036,000.00110,000View SEC Filing Icon  
8/3/2016Sell30,736$47.34$1,455,042.24140,720View SEC Filing Icon  
7/29/2016Sell20$43.95$879.00140,736View SEC Filing Icon  
7/20/2016Sell3,779$44.02$166,351.58140,756View SEC Filing Icon  
7/18/2016Sell5,465$44.31$242,154.15144,535View SEC Filing Icon  
7/8/2016Sell10,000$42.37$423,700.00150,000View SEC Filing Icon  
7/6/2016Sell5,960$40.27$240,009.20160,000View SEC Filing Icon  
7/1/2016Sell14,040$38.94$546,717.60165,960View SEC Filing Icon  
6/2/2016Sell20,000$36.74$734,800.00190,000View SEC Filing Icon  
5/12/2016Sell5,000$38.50$192,500.00200,000View SEC Filing Icon  
5/10/2016Sell15,000$36.75$551,250.00210,000View SEC Filing Icon  
5/9/2016Sell11,000$35.61$391,710.00228,718View SEC Filing Icon  
12/3/2015Sell6,000$35.50$213,000.00230,000View SEC Filing Icon  
8/17/2015Sell2,498$34.90$87,180.20View SEC Filing Icon  
8/14/2015Sell2,101$34.90$73,324.90View SEC Filing Icon  
6/8/2015Sell11,810$30.08$355,244.80View SEC Filing Icon  
3/9/2015Sell10,000$25.38$253,800.00View SEC Filing Icon  
11/30/2014Sell28,928$14.00$404,992.00View SEC Filing Icon  
See Full Table

Kevin S. Wilson Buying and Selling Activity at Heska

This chart shows Kevin S Wilson's buying and selling at Heska by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Heska Company Overview

Heska logo
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Read More

Today's Range

Now: $119.99
Low: $119.99
High: $119.99

50 Day Range

MA: $119.09
Low: $115.55
High: $119.99

2 Week Range

Now: $119.99
Low: $57.83
High: $120.03

Volume

N/A

Average Volume

241,932 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58